Re-conceptualizing the Clinical-High-Risk/Ultra-High-Risk Paradigm: A critique and reappraisal
A common practice when antipsychotics are found to be ineffective for schizophrenia is to prescribe a second, additional psychoactive medication. Now, a new study suggests that this practice is not supported by the research.
Large cohort study demonstrates that those with an intellectual disability are at an increased risk for movement disorder side effects of antipsychotics.
14-year study of a rural sample in China shows those who were married had higher rates of remission from schizophrenia.
20-year follow-up study finds that after four years, patients not prescribed antipsychotics have significantly better work functioning.
A prospective cohort study of those labeled high risk for psychosis finds a higher prevalence of antidepressant use among those who develop manic symptoms.
A large review and meta-analysis of 167 studies across 60 years dissects placebo-controlled randomized controlled trials of antipsychotic drugs.
No placebo controlled trials provide evidence of antipsychotics in first-episode psychosis.
Hearing Voices Network self-help groups are an important resource for coping with voice hearing, study finds.
A large longitudinal study finds once more that being prescribed antipsychotics significantly increases the risk of diabetes.
After a few weeks it became clear to me the complete lack of comprehension that I faced as a person claiming to have been cured of psychosis. Being a schizophrenic claiming to no longer suffer from schizophrenia only made me seem more schizophrenic due to the current culture of psychiatry.
A study examines the variables correlated with low levels of physical activity in persons diagnosed with psychosis in low and middle-income countries
Individuals with lived experience and clinicians share about barriers and facilitators to guided self-help CBT for voice hearing.
From Discover Magazine: Some children's symptoms of psychiatric disorders, including OCD, psychosis, and eating disorders, are caused by an autoimmune response to infections resulting in brain inflammation. "PANS...
A recent study published in Schizophrenia Research examines the incidence individuals deemed “Ultra High-Risk” (UHR) for psychosis and their neighborhood of residence
Participants diagnosed with schizophrenia with higher levels of self-reported depression have more accurate assessments of abilities.
Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.
Higher levels of sedentary behavior are associated with poorer cognitive functioning in patients diagnosed with schizophrenia.
Study finds frequency of social interactions predicts long-term remission in first-episode psychosis.
A new study finds that for those experiencing symptoms associated with psychosis, a low-level of physical activity is associated with receiving a diagnosis of a psychotic disorder.
In this piece for The Cut, Dyan Neary details the story of Frankie Perry, a man whose life was forever altered by being prescribed an...
Reduced usage of antipsychotics in first-episode psychosis was associated with improved executive functioning.
Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.
A meta-analysis of known risk factors for psychosis finds elevated risk with the presence of childhood trauma, adverse life events, and affective dysfunction.
A review article and meta-analysis of 18 articles published in the journal of Psychological Medicine reported effects of vitamin and/or mineral supplements on psychiatric symptoms in people diagnosed with schizophrenia. The study provides evidence of the beneficial effects of taking certain vitamins and minerals for improving symptoms associated with schizophrenia.